Metraipolis › archive › dc_22939194ca89

Polymorphisms in intron 1 of HLA-DRA differentially associate with type 1 diabetes and celiac disease and implicate involvement of complement system genes C4A… — Europe PMC PMID:41627183

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41627183
DOI
10.7554/elife.89068
License (as archived)
CC0-1.0
Archived
2026-10-06T08:26:25.682Z
SHA-256 of the archived text
9a3b4a6d423b9c5ba3c0a57f440587b60e725079a95be918a40770ec17c87d6e
Stable URL of this page
https://metraipolis.com/documento/dc_22939194ca89

How to cite

Polymorphisms in intron 1 of HLA-DRA differentially associate with type 1 diabetes and celiac disease and implicate involvement of complement system genes C4A… — Europe PMC PMID:41627183 — Europe PMC (en), https://europepmc.org/article/MED/41627183 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_22939194ca89 (Metraipolis archive dc_22939194ca89, sha256 9a3b4a6d423b9c5ba3c0a57f440587b60e725079a95be918a40770ec17c87d6e)
BibTeX
@misc{dc22939194ca89,
  title = {Polymorphisms in intron 1 of HLA-DRA differentially associate with type 1 diabetes and celiac disease and implicate involvement of complement system genes C4A… — Europe PMC PMID:41627183},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41627183},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_22939194ca89; sha256 9a3b4a6d423b9c5ba3c0a57f440587b60e725079a95be918a40770ec17c87d6e},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/41627183. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Polymorphisms in genes in the human leukocyte antigen (HLA) class II region comprise the most important inherited risk factors for many autoimmune diseases, including type 1 diabetes (T1D) and celiac disease (CD): both diseases are positively associated with the HLA-DR3 haplotype ( DRB1*03:01-DQA1*05:01-DQB1*02:01 ). Studies of two different populations have recently documented that T1D susceptibility in HLA-DR3 homozygous individuals is stratified by a haplotype consisting of three single nucleotide polymorphisms ('tri-SNP') in intron 1 of the HLA-DRA gene. In this study, we use a large cohort from the longitudinal 'The Environmental Determinants of Diabetes in the Young' (TEDDY) study to further refine the tri-SNP association with T1D and with autoantibody-defined T1D endotypes. We found that the tri-SNP association is primarily in subjects whose first-appearing T1D autoantibody is to insulin. In addition, we discovered that the tri-SNP is also associated with CD, and that the particular tri-SNP haplotype ('101') that is negatively associated with T1D risk is positively associated with risk for CD. The opposite effect of the tri-SNP haplotype on two DR3-associated diseases can enhance and refine current models of disease prediction based on genetic risk. Finally, we investigated possible functional differences between the individuals carrying high and low-risk tri-SNP haplotypes and found that differences in complement system genes C4A and C4B may underlie the observed divergence in disease risk.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: eLife, 2026 (prima pubblicazione 2026-02-02).
Identificativi: PMID 41627183 · PMCID PMC12863718 · DOI 10.7554/elife.89068.
Parole chiave degli autori: Human; Complement; Genetics; Inflammation; Genomics; Diabetes; immunology; Celiac Disease; T1d.
Descrittori MeSH principali: Celiac Disease; Diabetes Mellitus, Type 1; Genetic Predisposition to Disease; Polymorphism, Single Nucleotide; Introns; Complement C4a; HLA-DR alpha-Chains.
Pagina: https://europepmc.org/article/MED/41627183 — https://doi.org/10.7554/elife.89068. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T08:18:50.364Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.